ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
178 hedge funds and large institutions have $2.13B invested in Intra-Cellular Therapies Inc. in 2020 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 60 increasing their positions, 51 reducing their positions, and 38 closing their positions.
Holders
178
Holders Change
+2
Holders Change %
+1.14%
% of All Funds
3.16%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
41
Increased
60
Reduced
51
Closed
38
Calls
$30.1M
Puts
$21.3M
Net Calls
+$8.78M
Net Calls Change
+$314K
Top Buyers
1 |
WA
1
Wasatch Advisors
Salt Lake City,
Utah
|
$201M |
2 |
2
BlackRock
New York
|
$188M |
3 |
3
Goldman Sachs
New York
|
$19.2M |
4 |
SCM
4
Suvretta Capital Management
New York
|
$28.8M |
5 |
![]()
5
Adage Capital Partners
Boston,
Massachusetts
|
$24.2M |